Protein phosphatase 1 (PP1) is a major serine/threonine phosphatase that controls gene expression and cell cycle progression. The active mutant IPP5 (8-60hIPP5 m ), the latest member of the inhibitory molecules for PP1, has been shown to inhibit the growth of human cervix carcinoma cells (HeLa). In order to elucidate the underlying mechanisms, the present study assessed overexpression of 8-60hIPP5 m in HeLa cells. Flow cytometric and biochemical analyses showed that overexpression of 8-60hIPP5 m induced G2/M-phase arrest, which was accompanied by the upregulation of cyclin B1 and phosphorylation of G2/M-phase proteins ATM, p53, p21 cip1/waf1 and Cdc2, suggesting that 8-60hIPP5 m induces G2/M arrest through activation of the ATM/p53/p21 cip1/waf1 /Cdc2/ cyclin B1 pathways. We further showed that overexpression of 8-60hIPP5m led to delayed nuclear translocation of cyclin B1. 8-60hIPP5 m also could translocate to the nucleus in G2/M phase and interact with pp1α and Cdc2 as demonstrated by co-precipitation assay. Taken together, our data demonstrate a novel role for 8-60hIPP5m in regulation of cell cycle in HeLa cells, possibly contributing to the development of new therapeutic strategies for cervix carcinoma.
Introduction
Reversible protein phosphorylation regulates the biological activity of many protein complexes, which is regarded as a major mechanism of the control of cell cycle progression. It has been reported that the semi selective inhibitors of PPase, such as okadaic acid, cantharidin, and fostriecin, influence several aspects of cell cycle progression (Cohen, 2002) . An important Ser/Thr protein phosphatase, protein phosphatase-1 (PP1), regulates a series of physiological events, such as cell cycle, gene expression, protein synthesis, glycolipid metabolism and memory formation (Ceulemans and Bollen, 2004) . Its critical function in mitosis is evidenced by the occurrence of metaphase arrest in various eukaryotic cells after PP1 mutation or inhibition (Booher and Beach, 1989; Ohkura et al., 1989; Kinoshita et al., 1990) . The genetic and microtubule dynamics experiments also indicate that PP1 activity is necessary for the completion of mitosis (Cheng et al., 2000) . Furthermore, abnormally high expression of PP1 was observed in some tumor cells, indicating that PP1 might speed up the growth of malignant tumors (Sogawa et al., 1996) .
Cervical cancer is the leading cause of cancer-related death among women in most countries. It has been known that the high prevalence of HPV infection occurs in cervical cancer, and the two commonest HPV genotypes in cervical cancer were HPV 16 and 18 (Li et al., 2013; Raub et al., 2014) . Viral DNA integration into the host genome thereby deregulating host tumor suppressor proteins p53 and pRb via E6 and E7 proteins (Cheah et al., 2012) . It is known that the E6 and E7 genes of oncogenic HPV-16 and -18 play important roles in the early stages of malignant transformation and immortalization of cervical epithelial cells (Woodworth et al., 1989) . The inactivation of p53 and Rb by the E6 and E7 proteins, respectively, is an important step in maintaining abnormal cell proliferation through the disruption of normal cell cycle checkpoints (Boyer et al., 1996) . HPV-E6 protein forms a complex with E6-AP and subsequently interacts with p53, leading to ubiquitin dependent proteasomal degradation (Subramanian and Chinnappan, 2013) . E7 oncoprotein binds with pRb which controls the G1-S transition in cell cycle (Zhang and Tang, 2012) .
Protein phosphatase inhibitor-1 (PPI-1) is the first endogenetic molecule found to inhibit PP1 activity, when phosphorylated by protein kinase A (PKA) at Thr-35 (Nimmo and Cohen, 1978) . However, when Thr-35 is mutated to Asp, PPI-1 could inhibit the activity of PP1 without phosphorylation by PKA. The active mutant of IPP5 (8-60hIPP5 m ), the latest member of the inhibitory molecules for PP1, has been demonstrated to inhibit the activity of PP1 in vitro with a similar IC 50 as PPI-1 (Wang et al., 2008) . Previous studies from our laboratory have shown that 8-60hIPP5 m significantly inhibited the growth of human cervix carcinoma cells (HeLa) by inducing G2/M arrest (Zeng et al., 2012) . Now, we report that 8-60hIPP5 m -induced G2/M-arrest was accompanied by the upregulation and phosphorylation of G2/M-phase proteins ATM, p53, p21 cip1/waf1 , Cdc2 and cyclin B1. These findings suggest that active mutant IPP5 induces G2/M arrest through activation of ATM/ p53/p21 cip1/waf1 /Cdc2/cyclin B1 pathways. We also found that the overexpression of 8-60hIPP5 m led to cyclin B1 delayed nuclear translocation. These results suggest that 8-60hIPP5 m might be a functional growth inhibitor for cervix cancer cells. The mechanism for its inhibition could involve cell cycle regulation.
Materials and Methods

Reagents and cell culture
Human cervix carcinoma cells (HeLa) (ATCC, Manassas, VA, USA) were grown in DMEM medium supplemented with 10% (v/v) heat-inactivated fetal calf serum (FCS) (Hyclone, Logan, UT, USA), 4.5 g/liter D-glucose, nonessential amino acids (100 µM each), 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM glutamine at 37°C in a 5% CO 2 incubator. The wild type human IPP5 plasmid, pcDNA3.1/myc-His(-) B-hIPP5 (referred as phIPP5-B later), and active mutant hIPP5 plasmid (amino acids 8-60 of hIPP5, Thr"Asp-40), pcDNA3.1/myc-His(-)B-p8-60hIPP5 m (referred as p8-60hIPP5 m -B later) were kindly provided by Dr. Xiao-jian Wang at Zhejiang University (Zhejiang, China).
Cell transfection
The expression vectors phIPP5-B and p8-60hIPP5 m -B were transfected into HeLa cells using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) with pcDNA3.1/myc-His(-)B as a mock control. Stable cell lines overexpressing hIPP5 or 8-60hIPP5 m were selected by 600-1000 μg/ml G418 for 2-3 weeks, and cloned by limiting dilution. These stable cell lines were designated as HeLa-hIPP5 and HeLa-8-60hIPP5 m , respectively. The established stable cell lines were maintained in the same culture medium as used for parental HeLa cells. The stable expression of hIPP5 or 8-60hIPP5 m was confirmed by RT-PCR and Western blot.
Cell cycle analysis
HeLa cells transiently transfected with phIPP5-B, p8-60hIPP5 m -B or control vector were synchronized as described (Xia et al., 2002) . Briefly, 24 h after transfection, cells were serum-starved for 36 h, and refed with 10% FCS for 12h. Cells were then harvested, washed with PBS, fixed with 70% ethanol at 4°C overnight. Fixed cells were washed with cold PBS and incubated in 1 ml of PBS solution containing 100 µg of RNase A (Sigma Chemical Co., St. Louis, MO, USA) and 40 µg of propidium iodide (PI) (Sigma Chemical Co., St. Louis, MO, USA) for 30 min at 37°C. The DNA profiles were examined with a FACScan flow cytometer machine using the CellQuest program (Becton Dickinson, Mountain View, CA, USA).
For stable HeLa cells, cell synchronization was carried out by plating cells onto 6-well plates with a density that cells reached 50% confluence on the following day. Cells were then treated with 2 mMthymidine in complete medium (DMEM with 10% FBS) for 16 h, washed twice with DMEM-0% FBS, incubated for 8 h in complete medium, and treated again for 16 h with 2 mM thymidine in complete medium. The resulting G1/S-enriched cells were washed twice with DMEM-0% FBS and release into the cell cycle in the presence of complete medium for up to 26 h. Cells were harvested at indicated time, and treated as described above for FACS analysis. To observe mitosis progression, these cells were also examined under a microscope equipped with a CoolSNAPcf digital camera system (Photometrics, Roper Scientific, Tucson, AZ, USA), and stained with Giemsa.
Immunoprecipitation and nuclear translocation assay
Non-transfected and transfected HeLa cells were lysed in lysis buffer (Cell Signaling Technology Inc., Beverly, MA, USA). After mixing with Ni-NTA beads (Qiagen, Valencia, CA, USA), cell lysates were agitated gently overnight at 4°C. The beads were then washed four times in lysis buffer containing 10 mM amidazole and 0.1% TritionX-100, and Western blot performed. To examine the nuclear translocation of proteins, nuclear proteins were extracted using NE-PERTM nuclear reagents (Pierce, Biotechnology, Rockford, IL, USA), and analyzed by Western blot.
Western blot analysis
The protein concentrations were determined using the BCA Protein Assay kit (Pierce Biotechnology, Rockford, IL, USA). Samples containing equal amounts of protein were separated by 12% SDS-PAGE, and electrophoretically transferred to Protran nitrocellulose membranes (Schleicher & Schuell, Keene, NH, USA). Membranes were blocked with TBST containing 10% nonfat milk before incubating with primary 
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Asian Pacific Journal of Cancer Prevention, Vol 15, 2014 4103 DOI:http://dx.doi.org/10.7314/APJCP.2014.15.9 .4101 Effects of IPP5 on the Cell Cycle in Cervical Cancer Cells antibodies specific for cyclinA1, cyclinB1, (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), Myc, p21, PP1α, p-ATM, p-p53, p-p21, p-cdc2 (Cell Signaling Technology Inc., Beverly, MA, USA). After washing, the membranes were incubated with secondary antibodies conjugated with horseradish peroxidase (HRP) (Cell Signaling Technology Inc., Beverly, MA, USA). The HRP activity was detected using SuperSignal West Femto Maximum Sensitivity Substrate (Pierce Biotechnology, Rockford, IL, USA).
Statistical analysis
Pairwise comparisons were conducted using Student's t test. p values of less than 0.05 were considered statistically significant.
Results
Transfected HeLa cells express hIPP5 or 8-60hIPP5 m gene and related Myc fusion proteins
To investigate the role of IPP5 in cell cycle regulation, human cervical carcinoma HeLa cells were transfected with hIPP5 or 8-60hIPP5 m expression vector. RT-PCR showed that hIPP5 or 8-60hIPP5 m mRNA was expressed in the transfected cells ( Figure 1A) . Western blotting analysis further confirmed the expression of hIPP5 or 8-60hIPP5 m -Myc fusion protein in the transfected HeLa cells, but not in the non-transfected HeLa cells or the mock-transfected ones ( Figure 1B) . These results indicated that hIPP5 or 8-60hIPP5 m gene had been efficiently transfected into HeLa cells.
8-60hIPP5 m overexpression blocks the cell cycle at G2/M phase in human cervix carcinoma cells
Cell cycle distribution analysis showed that HeLa cells transfected with p8-60hIPP5 m exhibited a higher percentage of G2/M cells compared to other three groups, suggesting that 8-60hIPP5 m induced G2/M cell cycle arrest (Figure 2A ). We also treated HeLa cells stably expressing IPP5 with thymidine to obtain the G1/S phasesynchronous cells. Flow cytometry analysis of DNA content showed that the majority of control cells entered G2/M with 4N DNA at 6 h and returned to G1 at 9 h after thymidine withdrawal. In contrast HeLa-8-60hIPP5 m cells showed a significant delay in its return to 2N, which was most apparent at 12 h after thymidine withdrawal ( Figure  2B ). These results further demonstrated that 8-60hIPP5 m induced G2/M arrest in HeLa cells.
8-60hIPP5 m inhibits early and late mitotic progression
The role of 8-60hIPP5 m in regulating mitotic progression was further characterized by examining the 
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mitotic cells under a microscope for chromatinstaining in synchronized cells. Within 6 h after release from thymidine treatment, there was no significant difference in the number of mitotic cells among the four groups. At 7.5 h and 9 h, the amount of mitotic cells in HeLa-8-60hIPP5 m group was significantly lower than those of other groups. At 12 h, HeLa-8-60hIPP5 m cells were enriched in mitosis while most cells in the control groups returned to G0/G1 (data not shown). Similar results were obtained by Giemsa staining. Cells released from thymidine arrest were examined for distributions among mitotic stages. Based on the appearance of condensed chromatin, the largest fraction of control cells in metaphase occurred at 7.5 and 9 h for parental HeLa cells and mock-HeLa cells respectively, while the number of mitotic cells at all stages was reduced in HeLa-8-60hIPP5 m cells, indicating a delay in mitotic entry. However by 10.5 to 12 h, HeLa-8-60hIPP5 m cells showed significant enrichment in metaphase when most of the control cells returned to G1 (Figure 3 ). 8-60hIPP5 m changes the phosphorylation status and nuclear translocation of several cell cycle-regulatory proteins.
To investigate the mechanism involved in 8-60hIPP5 minduced G2/M cell cycle arrest, we examined the phosphorylation status of some cell cycle-regulatory factors. It was discovered that there was an increase in phosphorylation of ATM, p53, and p21 cip1/waf1 proteins in HeLa-8-60hIPP5 m cells after release from thymidine arrest ( Figure 4A ). Increased phosphorylation of ATM Ser1981 indicates activation of G2 checkpoint kinase. It has been reported that ATM is normally an inactive multimer, and activated by autophosphorylation at Ser1981 after double strand breaks or changes in the chromatin structure (Lavin and Kozlov, 2007; Luo et al., 2007) .
Moreover, phosphorylation of p53 Ser15, a target of ATM kinase, was noticed at 6 h after released from thymidine arrest. This is consistent with the known phenomenon that p53 Ser15 phosphorylation is dependent on ATM (Lavin and Kozlov, 2007) . Phosphorylation of p53 results in the stabilization and accumulation of this protein (Shirata et al., 2005) , which is important for its role in regulating downstream targets such as p21 cip1/waf1 .
To further explore the molecular mechanism of 8-60hIPP5 m -induced cell cycle arrest at G2/M phase, the expression of cyclins A1, B1 and Cdc2, which are regulators of the cell cycle G2-M transition (Dash et al., 2005) , were analyzed. As shown in Figure 4A , Cyclin B1, cyclin A1, and Tyr15-phosphorylated Cdc2, were still expressed in HeLa-8-60hIPP5 m cells at 12 h after release from thymidine arrest.
Cyclin B1 is a mitotic cyclin that accumulates in the cytosol during late S phase and G2 phases to form the inactive mitosis-promoting factor (MPF) with Cdc2. It enters the nucleus at the onset of mitosis and associates with condensed chromosomes in prophase and metaphase (Nurse, 1990; Pines and Hunter, 1991; Bailly et al., 1992; Roberts et al., 2002) . Considering that mitotic entry is related to cyclin B1 nuclear translocation, we assessed its expression in the nucleus. As shown in Figure 4B , in HeLa-8-60hIPP5 m cells, not until 7.5 h after release from thymidine arrest, did the nuclear level of cyclin B1 reach to that of other three groups at 6 h. This suggests that the nuclear translocation of cyclin B1 delayed for about 1.5 hour in HeLa-8-60hIPP5 m cells. This result is consistent with the Giemsa staining result in which fewer mitotic cells were found at 7.5 h in HeLa-8-60hIPP5 m cells. These findings lend further support to the notion that 8-60hIPP5 m induces a delay in mitotic entry.
Figure 3. 8-60hIPP5m Delays Early Mitotic Progression.
Stably transfected HeLa cells and parental HeLa cells grown on coverslips were synchronized by thymidine arrest, released, and stained with Giemsa at 7.5, 9, 10.5, 12h and scored by chromatin appearance for numbers of cells in prophase (Pro), prometaphase (Prometa), metaphase (Meta), anaphase (Ana), and telophase (Telo). The total numbers of counted cells ranged between 1,100 and 1,600 
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8-60hIPP5 m translocates into the nucleus at G2/M phase and interacts with PP1αand cdc2
It has been reported that the PP1 catalytic subunit, PP1α, translocates into the nucleus in G2/M, and dephosphorylates a variety of nuclear structural proteins that are substrates of the cyclin B/cdc2 kinase (Mumby and Walter, 1993) , thus promotes the completion of mitosis. To understand the effect of 8-60hIPP5 m on mitosis, we assessed its expression in the nucleus, and analyzed the proteins that 8-60hIPP5 m interacted with. At 6 h after release from thymidine arrest, 8-60hIPP5 m level was significantly enhanced in the nucleus of HeLa-8-60hIPP5 m cells ( Figure 5A ). Immunoprecipitation assay revealed that 8-60hIPP5 m interacted with PP1α and cdc2 ( Figure 5B ). These results suggest that 8-60hIPP5 m might translocate into the nucleus at G2/M phase where it interacts with PP1α and inhibits its activity, resulting in the delay of mitotic exit. 8-60hIPP5 m may also interact with cdc2 and regulate its activity, through which it influences mitosis progression.
Discussion
In this study, we showed that overexpression of IPP5 resulted in G2/M arrest through inhibiting early and late mitotic progression. This study is an extension of our earlier work in which it was discovered that 8-60hIPP5 m caused cell growth retardation in vitro (Zeng et al., 2012) . In eukaryotic organisms, cell cycle progression is regulated to a large extent by the reversible phosphorylation of various proteins. PP1 plays an important role during cell cycle progression, especially during mitosis. There is a lot of evidence demonstrating the involvement of both phosphorylation and dephosohprylation in cell cycle control. Neutralizing PP1 by anti-PP1 antibodies, mutation of PP1, or treatment with various natural phosphatase inhibitors such as okadaic acid, calyculin-A, tautomycin, microcystin-LR, fostriecin and cantharidin have been shown to cause abnormalities in cell cycle progression and checkpoint abrogation (Axton et al., 1990; Kinoshita et al., 1990; Edelson et al., 2011; Honkanen et al., 2012; Rubiolo et al., 2012) . In particular, fostriecin and cantharidin have been shown to force cells to go through the cycle prematurely and into mitosis, resulting in multiple aberrant mitotic spindles and apoptotic cell death (Verma et al., 2012; Theobald et al., 2013) . In human cells, PP1 could act as a histone H1 phosphatase, which is required for chromatin decondensation during the exit from mitosis (Paulson et al., 1996) . PP1 recruitment to the spindle pole body (SPB) component Cut12 sets a threshold for Polo's feedback-loop activity that locks the cell in interphase until Cdc25 pushes MPF activity through this barrier to initiate mitosis (Grallert et al., 2013) . Subcellular localizations of PP1 isoforms are different at mitosis. PP1α is located at the centrosome, while PP1γ and PP1δ are associated with mitotic spindles and chromosomes, respectively (Andreassen et al., 1998) . This might explain why PP1 mutations and inhibitors cause complex abnormal phenotypes, including delayed transition of metaphase to anaphase, condensed chromosomes, formation of abnormal spindles, microtubule dynamics and chromosome separation malfunction, and defect of cytokinesis. Our results also demonstrated that 8-60hIPP5 m could suppress cell cycle progression in human cervix carcinoma HeLa cells.
To investigate the mechanism how IPP5 regulate cell cycle in HeLa cells, we analyzed the cell cycle progression by FACS in both transiently and stably 8-60hIPP5 m transfected cells. After synchronized with thymidine, the mitotic entry of HeLa-p8-60hIPP5m cells was significantly delayed. This observation was confirmed by Giemsa staining.
Cells progress through each phase in a tightly controlled manner. This process is regulated by cyclins and cyclin-dependent kinases. Disruption of tumor suppressor protein p53 is a common event in cervical cancer (Zhou et al., 2012) . 8-60hIPP5m stimulates cellular responses through the activation of ATM/p53/p21 cip1/waf1 signal pathways. Accumulation of phosphorylated p53 and p21 cip1/waf1 proteins, which may have been preceded by the increased expression of their upstream activators ATM, MDM2, and Chk1/2, is accompanied by reduced hyperphosphorylation of Cdc25C that is required to promote Cdc2 dephosphorylation during G2 arrest A, The nuclear translocation of 8-60hIPP5m during G2/M phase in HeLa cells. Cells were treated as described in Fig 4B. B , The interaction of 8-60hIPP5m with pp1α and CDK1 respectively in HeLa cells. HeLa-hIPP5, 8-60hIPP5m, HeLa-mock and parental HeLa cells were synchronized by thymidine arrest, released, and harvested at 6h for immunoprecipitation. HeLa-hIPP5, HeLa-p8-60hIPP5m , HeLa-mock, and parental HeLa cells were serum-starved for 24 h, stimulated with TNFα for 10 min, harvested and lysed. Lysates were incubated with Ni-NTA beads. The beads were collected by centrifugation, and samples were immunoblotted using PP1α antibody 5A) 5B) (Poggioli et al., 2001) . p53 inhibits Cdc2 through the activation of p21 cip1/waf1 and through its feedback loop to regulate ATM (Lavin and Kozlov, 2007) . Activated ATM phosphorylates several downstream targets, including Brca1, Nbs1, p53, and Chk2 (Dahl et al., 2005; Lavin and Kozlov, 2007; Zhao et al., 2008) , temporarily blocking the cell cycle to facilitate the repair of lesions before cell division. Recently, it is reported that p53 is regulated by MDM2, which associates with Daxx. Upon DNA damage Daxx Ser564 is phosphorylated at Ser564 by ATM, and precedes p53 activation (Tang, et al., 2013) . On the contrary, PP1 acts as a negative regulator in the p53 signaling pathway. PP1 directly interacts with Mdmx and specifically dephosphorylates Mdmx at Ser367. The dephosphorylation of Mdmx increases its stability and thereby inhibits p53 activity (Lu et al., 2013) . Inactivation of the Cdc2-cyclin B1 complex through phosphorylation of Cdc2 Tyr-15 and Thr-14 results in G2/M cycle arrest (Chow et al., 2003) . Our results showed that 8-60hIPP5m increased phosphorylation of several cell cycle regulatory proteins that are involved in G2/M arrest in which Cdc2 is hyperphosphorylated. This may suggest that 8-60hIPP5m disrupts the dephosphorylation of Cdc2, a process that normally occurs in late G2 and early M phase Therefore it is reasonable to infer that 8-60hIPP5m-induced G2/M arrest is a result of cellular responses initiated by phosphorylation of Cdc2 on Thr14 and Tyr15. Furthermore, in HeLa-8-60hIPP5 m cells, cyclin B1 accumulated along with Tyr15-phosphorylated Cdc2, suggesting that 8-60hIPP5 m may block the activation of MPF, in turn delaying cellular transition from the G2 phase into the M phase.
In addition, ERK phosphorylation was impaired in both transiently and stably 8-60hIPP5 m transfected cells (Zeng et al., 2012) . It is known that ERK promotes Cdc2/ cyclin B activation and M phase progression, and that suppression of the MKK/ERK signaling would sufficiently delay mitotic entry and Cdc2 activation (Wright et al., 1999) . Importantly, ERK inactivation delays cyclin B1 nuclear translocation, as well as cell progression from metaphase into anaphase (Roberts et al., 2002) . This suggests that in addition to promoting M phase entry by facilitating activation of Cdc2-cyclin B and cyclin B1 translocation, MKK/ERK pathway is important for mitotic progression and mitotic exit.
It has been reported that PP1 catalytic subunit, PP1α, translocates into the nucleus at G2/M phase, and dephosphorylates a variety of nuclear structural proteins that are substrates of the cyclin B/Cdc2 kinase, including histone H1, lamins, microtubule-associated proteins, and cyclin B/Cdc2 complex. These nuclear structural proteins must be inactivated before progression to anaphase. So PP1 may play a role in promoting the completion of mitosis. In this study, we also found that 8-60hIPP5 m translocated into the nucleus at G2/M phase. Furthermore, 8-60hIPP5 m could interact with PP1α and Cdc2. These results suggest that 8-60hIPP5 m might inhibit PP1α activity and maintain the phosphorylation of Cdc2 through its nuclear translocation at G2/M phase, leading to the delay in mitotic exit.
In summary, we report a novel role for 8-60hIPP5 m in the control of G2/M cell cycle progression, a process that involves the activation of ATM/p53/p21 cip1/waf1 /Cdc2/ cyclin B1 pathways. It was discovered that 8-60hIPP5 m translocated into the nucleus at G2/M phase, where it interacted with Cdc2 and PP1α, and disrupted the dephosphorylation of Cdc2. In addition, 8-60hIPP5 minduced G2/M arrest of HeLa cells involved the delayed nuclear translocation of cyclin B1. These results suggest that 8-60hIPP5 m might be explored as a therapeutic strategy, either alone or in combination with chemotherapy.
